|
ETX-636 dose expansion in combination with fulvestrant Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Faslodex
Newport Beach, California1 trial
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Hoag Memorial Hospital Presbyterian
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.